List of SBIR/STTR awards granted to PDX Pharmaceuticals, Inc.
PDX Pharmaceuticals, Inc.Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to PDX Pharmaceuticals, Inc. in September, 2021 for $1,898,361.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA265752-01A1 | Phase II | 1,898,361 | September 1, 2021 | |||||||
A SBIR Phase I contract was awarded to PDX Pharmaceuticals, Inc. in September, 2021 for $378,030.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA265751-01A1 | Phase I | 378,030 | September 23, 2021 | |||||||
A SBIR Phase II contract was awarded to PDX Pharmaceuticals, Inc. in June, 2018 for $1,507,301.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA217534-02 | Phase II | 1,507,301 | June 1, 2018 | |||||||
A SBIR Phase I contract was awarded to PDX Pharmaceuticals, Inc. in May, 2017 for $224,965.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44CA217534-01 | Phase I | 224,965 | May 16, 2017 | |||||||
A SBIR Phase I contract was awarded to PDX Pharmaceuticals, Inc. in August, 2017 for $325,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43TR001906-01A1 | Phase I | 325,000 | August 15, 2017 | |||||||
A SBIR Phase I contract was awarded to PDX Pharmaceuticals, Inc. for $200,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | N43CA130078 | Phase I | 200,000 | ||||||||
A SBIR Phase II contract was awarded to PDX Pharmaceuticals, Inc. for $1,000,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 261201300078C-2-0-1 | Phase II | 1,000,000 | ||||||||
A STTR Phase I contract was awarded to PDX Pharmaceuticals, Inc. for $299,741.0 USD from the U.S. Department of Health & Human Services. | STTR | 1R41DK094571-01 | Phase I | 299,741 | ||||||||
A SBIR Phase I contract was awarded to PDX Pharmaceuticals, Inc. in July, 2023 for $400,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44CA285233-01 | Phase I | 400,000 | July 6, 2023 | |||||||
A SBIR Phase II contract was awarded to PDX Pharmaceuticals, Inc. in December, 2022 for $932,751.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44CA265751-02 | Phase II | 932,751 | December 1, 2022 |
